$22.44
+0.25 (+1.13%)
Performance
1D
—
1W
—
1M
—
3M
-8.41%
6M
+28.08%
1Y
+182.62%
YTD
+7.78%
Open$22.19
Previous Close$22.19
Day High$22.71
Day Low$22.05
52W High$27.65
52W Low$7.15
Volume—
Avg Volume823.8K
Market Cap2.51B
P/E Ratio—
EPS$-2.41
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$22.49
Below
SMA 200
$14.32
Above
RSI (14)
37.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
20 analysts
Price Target
+486.0% upside
Current
$22.44
$22.44
Target
$131.49
$131.49
$82.08
$131.49 avg
$141.61
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.89M | 603.96M | 550.96M |
| Net Income | -272,018,698 | -173,219,826 | -162,867,502 |
| Profit Margin | -3,060.0% | -28.7% | -29.6% |
| EBITDA | -283,866,027 | -273,358,868 | -247,027,649 |
| Free Cash Flow | — | -130,399,233 | -192,377,550 |
| Rev Growth | — | +13.0% | +19.7% |
| Debt/Equity | — | 0.20 | 0.19 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |